Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-22

FDA Approved: REPAGLINIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original-application generic repaglinide for use in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repaglinide (Repaglinide)

Snippet

ORIG AP for REPAGLINIDE (REPAGLINIDE)